https://www.selleckchem.com/pr....oducts/anlotinib-al3
Four of the 19 HCV Ab positive patients didn't meet any of the registered risk factors. Conclusions This study confirms the problem of underdiagnosis of HCV, which is both related to the fact that not all risk groups are being screened and to the fact that patients are identified beyond the risk groups. These results, as well as the current changes in treatment options and their reimbursement, justify a reconsideration of the current recommendations for screening of HCV. To develop the most effective screening strategy in Fland
Like
Comment
Share
